Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Ark Genomic Revolution Multi-Sector ETF (NY: ARKG)
55.72 USD  -1.74 (-3.03%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 10, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Ark Genomic Revolution Multi-Sector ETF
Sector
Exchange Traded NY
Net Assets 178.59M
Inception Date
Related Funds
Quote
Price 55.72
Volume 715,400
Last Trade Jul 10, 8:00pm
Change (%)
-1.74 (-3.03%)
Prev. Close 57.46
YTD %
+67.08%
Dividend Yield N/A
Performance
YTD
+22.37 (67.08%)
1 Month
+13.12 (30.80%)
3 Month
+22.19 (66.18%)
6 Month
+21.31 (61.93%)
1 Year
+22.08 (65.64%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Top ETF Stories of 1H & Investing Ideas for 2H
Cloud computing, e-commerce, and internet are among the best performing areas of 2020 as they all benefit from the current crisis. Read More
from Blogs - TalkMarkets
Genomics Long-Term Trajectory Shines a Light on ARKG
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is already one of the best-performing healthcare ETFs over the past several years, but with a slew of secular tailwinds behind the genomics... Read More
from ETF Trends
Top News
More News
ARKG ETF Experiences Big Inflow
Symbols mentioned in this story: ARKG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded... Read More
from ETF Channel
Genomics Long-Term Trajectory Highlights ARKG
The ARK Genomic Revolution Multi-Sector Fund ( ARKG ) is already one of the best-performing healthcare ETFs over the past several years, but with a slew of secular tailwinds behind the genomics... Read More
from ETFdb
ARK Invest: The Rise of the Importance of Virtual Care Amid Covid-19
With a global healthcare crisis leading to a worldwide financial crisis, investors are looking to disruptive companies that can benefit in times of uncertainty and volatility. These types of funds can... Read More
from ETF Trends
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide... Read More
from Blogs - TalkMarkets
ETF of the Week: ARK Genomic Revolution Multi-Sector Fund (ARKG)
ETF Trends CEO Tom Lydon discussed the ARK Genomic Revolution Multi-Sector Fund (ARKG) on this week’s “ETF of the Week” podcast with Chuck Jaffe on the MoneyLife Show. The ARK Genomic Revolution ETF... Read More
from ETF Trends
4 Sector ETFs Up More Than 30% in First-Half 2020
While many corners of the equity world witnessed a solid run, a few sector ETFs performed incredibly, thereby comfortably crushing the broader markets. Here are four such ETFs from various industries. Read More
from Blogs - TalkMarkets
Noteworthy ETF Inflows: ARKG
Symbols mentioned in this story: ARKG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded... Read More
from ETF Channel
Coronavirus Flareup Sparked a Great Week for Active Genomics ETF
The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) jumped 5.34% last week, run fueled by concerns of a second wave of the novel coronavirus and news that some of the ETFs components are making... Read More
from ETF Trends
Coronavirus Sparked a Great Week for Active Genomics ETF
The ARK Genomic Revolution Multi-Sector Fund ( ARKG ) jumped 5.34% last week, run fueled by concerns of a second wave of the novel coronavirus and news that some of the ETFs components are making... Read More
from ETFdb
Biotech ETFs Rally After Inovio Locks in DOD Coronavirus Deal
Biotechnology sector-related exchange traded funds were among the leaders on Tuesday after the Department of Defense provided funding to Inovio Pharmaceuticals (NasdaqGS: INO) to scale up manufacturing... Read More
from ETF Trends
Biotech ETFs Surge After Invitae Acquires ArcherDX
Biotechnology sector-related exchange traded funds were among the leaders on Monday after Invitae Corp. (NYSE: NVTA) announced a $1.4 billion deal for ArcherDX, potentially bolstering the genetic... Read More
from ETF Trends
Two Disruptive ETFs for One Vital Theme
An important though often overlooked trait of disruptive technologies is that many often intersect with each other. The healthcare sector is an epicenter of that intersection. The ARK Innovation ETF... Read More
from ETF Trends
Two Disruptive ETFs for One Crucial Theme
An important though often overlooked trait of disruptive technologies is that many often intersect with each other. The healthcare sector is an epicenter of that intersection. The ARK Innovation ETF (... Read More
from ETFdb
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.